Finance

Beta
Lists
XGN:NASDAQ
Exagen Inc
$4.54
-3.61%
(-0.17) 1D
Jul 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XGN...
Open
$4.69
High
$4.76
Low
$4.46
Mkt. cap
109.69M
Avg. vol.
339.36K
Volume
127.80K
52-wk high
$12.23
52-wk low
$2.60
EPS
-$0.88
Beta
2.02
Shares outstanding
24.16M
No. of employees
218
Open
$4.69
High
$4.76
Low
$4.46
Mkt. cap
109.69M
Avg. vol.
339.36K
Volume
127.80K
52-wk high
$12.23
52-wk low
$2.60
EPS
-$0.88
Beta
2.02
Shares outstanding
24.16M
No. of employees
218
News stories
From sources across the web
About Exagen Inc
CEO-
Employees218
Founded2002
HeadquartersVista, California, United States
SectorBiotechnology
Websiteexagen.com
Analyst ratings
Based on 5 analysts giving stock ratings to XGN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for XGN in the last 3 months.
Highest
Current $4.54
$8.00 (+76.21%)
Average
$8.00 (+76.21%)
Lowest
$8.00 (+76.21%)
Analyst
Recommendation
Action
Price target
Projected
Date
Max Masucci
Roth MKM
Buy
Initiated
$8.00
+76.2%
06/25/2026
Unknown Analyst
Roth MKM
Buy
Initiated
$8.00
+76.2%
06/24/2026
Andrew Brackmann
William Blair
Buy
Reiterated
-
-
05/12/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Maintained
$8.00
+76.2%
05/11/2026
Mark Massaro
BTIG
Buy
Reiterated
$8.00
+76.2%
05/12/2026
Daniel Brennan
TD Cowen
Buy
Maintained
$8.00
+76.2%
05/11/2026
Anderson Schock
B. Riley Securities
Buy
Maintained
$8.00
+76.2%
03/11/2026
William Bonello
Craig-Hallum
Buy
Reiterated
$10.00
+120.3%
03/11/2026
Paul Knight
KeyBanc
Buy
Maintained
$10.00
+120.3%
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
17.20M
17.24M
16.63M
17.31M
Cost of goods sold
6.81M
7.17M
7.42M
7.10M
Cost of revenue
6.81M
7.17M
7.42M
7.10M
Research and development expenses
1.48M
1.73M
1.76M
1.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.54M
11.44M
12.42M
12.07M
Operating expense
13.02M
13.18M
14.18M
13.62M
Total operating expenses
19.83M
20.34M
21.61M
20.72M
Operating income
-2.63M
-3.10M
-4.98M
-3.41M
Other non operating income
-
-
-
-132.00K
EBT including unusual items
-4.40M
-7.09M
-4.66M
-3.93M
EBT excluding unusual items
-3.67M
-4.42M
-6.26M
-4.81M
Income tax expense
37.00K
1.00K
13.00K
36.00K
Effective tax rate
-0.84%
-0.01%
-0.28%
-0.92%
Other operating expenses
-
-
-
-
Net income
-4.44M
-7.09M
-4.67M
-3.97M
Net profit margin
-25.81%
-41.10%
-28.10%
-22.92%
Earnings per share
-0.18
-0.31
-0.27
-0.20
Interest and investment income
85.00K
3.00K
43.00K
-
Interest expense
-1.12M
-1.32M
-1.33M
-1.27M
Net interest expenses
-1.04M
-1.32M
-1.29M
-1.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.16M
-2.49M
-4.38M
-2.82M
Gain or loss from assets sale
-6.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer